Biswajit Chowdhury

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.

H Nagata, A S Worobec, Chang Kyu Oh et al. · Proceedings of the National Academy of Sciences · 1995 · 878 citations

The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension

Biswajit Chowdhury, Albert Z. Luu, Vincent Z. Luu et al. · Biochemical and Biophysical Research Communications · 2020 · 136 citations

Hypertension, Pulmonary Arterial Hypertension, Cardiovascular Disease +7

Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease

Tamique Mason, Otávio R. Coelho‐Filho, Subodh Verma et al. · JACC. Cardiovascular imaging · 2021 · 90 citations

Metabolic Syndrome, Cardiovascular Disease, Atherosclerosis +11

Long-Term Correction of Sandhoff Disease Following Intravenous Delivery of rAAV9 to Mouse Neonates

Jagdeep S. Walia, Naderah Altaleb, Alexander Bello et al. · Molecular Therapy · 2014 · 87 citations · Full text

Murine Hyaluronidase 2 Deficiency Results in Extracellular Hyaluronan Accumulation and Severe Cardiopulmonary Dysfunction

Biswajit Chowdhury, Richard Hemming, Sabine Hombach‐Klonisch et al. · Journal of Biological Chemistry · 2012 · 68 citations · Full text